Diseases & Conditions Market Research Reports & Industry Analysis
Insomnia is a common condition in which one has trouble going to sleep or staying asleep. This condition can range from weak to strong, depending on how often it occurs and for how long. Insomnia can be ongoing or acute. Chronic insomnia means having symptoms at least 3 nights a week for more than a month. Acute insomnia lasts for less time. Some people who have insomnia will have trouble falling asleep. Other people may fall asleep easily but, then wake up.
Diseases & Conditions Industry Research & Market Reports
-
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases
... expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 8.3% CAGR ... Read More
-
Nocturia Drugs
... CAGR of 6.1% over the analysis period 2024-2030. Low Nocturnal Bladder Capacity Indication, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.0 Billion by the end ... Read More
-
Non-Hodgkin Lymphoma Therapeutics
... at a CAGR of 7.0% over the analysis period 2024-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$10.1 Billion by the end of the ... Read More
-
Ocular Implants
... CAGR of 4.2% over the analysis period 2024-2030. Glaucoma Implants, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$6.5 Billion by the end of the analysis ... Read More
-
Photography Equipment
... CAGR of -9.2% over the analysis period 2024-2030. Cameras, one of the segments analyzed in the report, is expected to record a -10.4% CAGR and reach US$2.1 Billion by the end of the analysis period. ... Read More
-
Automotive Closure
... CAGR of 6.7% over the analysis period 2024-2030. Light-Duty Vehicles, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$23.3 Billion by the end of the analysis ... Read More
-
Security and Law Enforcement Robots
... Billion by 2030, growing at a CAGR of 13.0% over the analysis period 2024-2030. Unmanned Logistics Application, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$5.5 ... Read More
-
qPCR Reagents
... CAGR of 7.4% over the analysis period 2024-2030. Dye-Based qPCR Reagents, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$2.5 Billion by the end of the ... Read More
-
Intrathecal Pumps
... CAGR of 5.1% over the analysis period 2024-2030. Morphine, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$115.9 Million by the end of the analysis period. ... Read More
-
Life Science Analytics
... at a CAGR of 13.3% over the analysis period 2024-2030. Life Science Analytics Services, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$44.7 Billion by the ... Read More
-
Livestock Monitoring
... CAGR of 9.5% over the analysis period 2024-2030. Livestock Monitoring Hardware, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Pyrogen Testing
... CAGR of 10.4% over the analysis period 2024-2030. Pyrogen Testing Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$1.1 Billion by the ... Read More
-
Anticoagulants
... 9.2% over the analysis period 2024-2030. NOACs, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis period. Growth in ... Read More
-
Alpha Emitters
... CAGR of 20.9% over the analysis period 2024-2030. Bone Metastasis Application, one of the segments analyzed in the report, is expected to record a 20.4% CAGR and reach US$993.8 Million by the end of the ... Read More
-
Attitude and Heading Reference Systems
... Million by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Conventional AHRS, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$363.9 Million ... Read More
-
Autoimmune Disease Diagnosis
... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More
-
Automated Passenger Information Systems
... 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Automated Passenger Information Systems, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$9.7 Billion ... Read More
-
Automotive Paints
... CAGR of 2.6% over the analysis period 2024-2030. Clearcoat, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$1.9 Billion by the end of the analysis period. ... Read More
-
Bloodstream Infection Testing
... at a CAGR of 6.9% over the analysis period 2024-2030. Conventional Testing, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$12.7 Billion by the end of ... Read More
-
Brewing Enzymes
... CAGR of 5.7% over the analysis period 2024-2030. Amylase, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$271.7 Million by the end of the analysis period. ... Read More
-
Burn Care
... CAGR of 3.9% over the analysis period 2024-2030. Advanced Burn Care, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.5 Billion by the end of the ... Read More
-
Cancer Diagnostics
... CAGR of 5.8% over the analysis period 2024-2030. Imaging, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$95.3 Billion by the end of the analysis period. ... Read More
-
Antimicrobial Textiles
... CAGR of 5.1% over the analysis period 2024-2030. Synthetic Organic Compounds, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$12.0 Billion by the end of the ... Read More
-
Artificial Pancreas Device Systems
... 2030, growing at a CAGR of 18.8% over the analysis period 2024-2030. Threshold Suspended Device Systems, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$1.2 Billion ... Read More
-
Automotive Camshaft
... CAGR of 4.4% over the analysis period 2024-2030. Forged Camshaft, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$2.4 Billion by the end of the analysis ... Read More